XETRA · MRK.DE
Merck KGaA
€151.55+€1.25 (+0.83%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.36% below the high.
Loading market information…
XETRA · NMI.DE · EUR
Stock price
Quote as of Oct 12, 2022, 03:36 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Aladdin Healthcare Technologies SE’s quoted price sits in the lower half of its reported 52-week range, 91.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Aladdin Healthcare Technologies SE, alongside its subsidiary Aladdin Healthcare Technologies Ltd, crafts software platforms for the secure safeguarding and efficient organization of medical data, primarily utilizing blockchain technology. The company exhibits profound expertise in cutting-edge domains such as blockchain, machine learning, and artificial intelligence. Its advanced offerings include an AI-driven platform for early diagnosis through sophisticated brain imaging analysis, a Health Risk Assessment platform designed to gauge patient susceptibility to cardiovascular, diabetic, and renal conditions, and an AI-powered Drug Discovery platform. This latter tool is instrumental in identifying small molecule compounds effective against various age-related ailments like Alzheimer's and Parkinson's diseases, as well as SARS-CoV-2. Employing a synergistic blend of blockchain, machine learning, artificial intelligence, and sophisticated predictive data analytics, Aladdin Healthcare Technologies focuses on the proactive detection of chronic illnesses. Established in 2014, its operations are based in Berlin, Germany.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:10 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€151.55+€1.25 (+0.83%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.36% below the high.
€49.85+€1.89 (+3.94%)
Bayer Aktiengesellschaft’s quoted price sits in the upper half of its reported 52-week range, 7.55% below the high.
€43.10+€0.21 (+0.49%)
Siemens Healthineers AG’s quoted price sits in the upper half of its reported 52-week range, 13.28% below the high.
MX$953.08MX$0.00 (0.0%)
Bayer AG’s quoted price sits in the upper half of its reported 52-week range, 5.56% below the high.
€47.68+€0.68 (+1.44%)
Fresenius SE & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 9.98% below the high.
€79.70+€1.80 (+2.31%)
BioNTech SE’s quoted price sits in the lower half of its reported 52-week range, 24.6% below the high.
€293.60-€4.90 (-1.64%)
Sartorius AG’s quoted price sits in the upper half of its reported 52-week range, 1.71% below the high.
€40.88-€0.59 (-1.42%)
Fresenius Medical Care AG & Co. KGaA’s quoted price sits in the lower half of its reported 52-week range, 14.01% below the high.
